PRIN 2022 PNRR

lista dei progetti ammessi a finanziamento

Progetti ammessi a finanziamento nell'ambito del bando PRIN 2022 – PNRR (D.D. 1409 del  14/09/2022) 

(PDF)

Data inizio: 30-11-2023 

Data fine: 29-11-2025

TITOLO 

CUP 

RESPONSABILE  SCIENTIFICO

Agricultural By Products for Healthcare Ecologic Surfactant  Production

H53D23008030001 

Maria Pia Argentieri

Optogenetic mediated muscle organoid as a pharmacological  tool for drug delivery and bioenergetic study: a novel  therapeutic platform for neuromuscular disorders

H53D23011110001 

Ornella Cappellari

Sigma receptors, histone deacetylases and matrix  metalloproteinases for a multitarget approach to uveal  melanoma

H53D23007880001 

Marco Catto

Biased Agonists For Formyl Peptide Receptor 2 (Fpr2) As  New Anti-Inflammatory And Pro-Resolving Agents: An  Innovative Approach For The Treatment Of Chronic  Inflammatory Diseases

H53D23011060001 

Enza Lacivita

Selective Induced Generation of new Active Species using  Light, Organocatalysis, and Flow Technology

H53D23008070001 

Renzo Luisi

Artificial Intelligence Driven Design of Protease Inhibitors to  Treat Neglected Tropical Disease Caused by Trypanosoma  Cruzi, Dengue and Zika Viruses

H53D23007930001 

Nicolotti Orazio

Nature-Inspired structures: Fungal metabolites for a  sustainable semi-synthetic approach to the discovery of new  multi-target anti-Alzheimer's drugs

H53D23007940001 

Luca Piemontese

Preclinical And Clinical Evaluation Of Conjugated Linoleic  Acid Effects Against The Progression Of Amyotrophic Lateral  Sclerosis

H53D23008970001 

Sabata Pierno

The Second Life of Posidonia Oceanica: Sustainability-guided  Isolation and Valorization of its Main Constituents

H53D23007860001 

Paola Vitale

10 

Biocatalytic Units Based On Enzyme Crystals For Efficient  And Continuous CO2 Conversion Into Chemicals

H53D23008800001 

Ciro Leonardo Pierri

11 

AID-CARE: Artificial Intelligence-aided Design of  CAnnabinoid REceptor subtype 2 (CB2R) Multitarget ligands:  a new strategy for the treatment of inflammation

H53D23008020001 

Marialessandra  

Contino



pubblicato il 19/03/2026 ultima modifica 20/03/2026

Azioni sul documento